Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026

Go back to Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026
AKEBIA THERAPEUTICS (NASDAQ: AKBA) Delayed: 1.07 +0.05 (4.90%)
Previous Close $1.02    52 Week High $13.20 
Open $1.05    52 Week Low $7.00 
Day High $1.08    P/E N/A 
Day Low $1.00    EPS $0.00 
Volume 22,933,787